Posts Tagged ‘American Medical Association’

Pushback against the war on ivermectin

September 8, 2021

The American Medical Association has joined the campaign to discourage people from using invermectin as a treatment for COVID-19.  But not all physicians are willing to accept the AMA’s judgment.

The following is a letter from Jane M. Orient, M.D., executive director of Association of American Physicians and Surgeons, to Gerald E. Harmon, M.D., president of the American Medical Association.

The AMA has taken the startling and unprecedented position that American physicians should immediately stop prescribing, and pharmacists should stop honoring their prescriptions for ivermectin for COVID-19 patients.  The AMA is thus contradicting the professional judgment of a very large number of physicians, who are writing about 88,000 prescriptions per week.  It also contradicts the Chairman of the Tokyo Medical Association, Haruo Ozaki, who recommended that all doctors in Japan immediately begin using Ivermectin to treat COVID.

AMA claims that ivermectin is dangerous and ineffective despite the safe prescription of billions of doses since 1981, and the mostly favorable results of 63 controlled studies in COVID-19.

AMA does not specify any recommended early treatments, but simply urges face masks, distancing, and vaccination.

Our members would appreciate clarification of the AMA’s stand on the following questions:

  • What are the criteria for advocating that pharmacists override the judgment of fully qualified physicians who are responsible for individual patients?
  • What are the criteria for forbidding off-label use of long-approved drugs, which constitute at least 20 percent of all prescriptions?
  • On what basis does AMA demand use only within a clinical trial for ivermectin, but call for virtually universal vaccination outside of controlled trials, despite FDA warnings of potential cardiac damage in healthy young patients, and no information about long-term effects?

We believe that these questions get to the heart of issues of physician and patient autonomy, as well as scientific principles such as the need for a control group in experiments.

We look forward to your response.

Ivermectin is a drug originally developed as a cure for parasitic disease, and has come to be used as an off-label treatment for bacterial and virus diseases.  Many reputable physicians prescribe it for COVID-19—not as a substitute for vaccination, but as a supplement for vaccines or as an alternative when vaccines are not available or not medically recommended.

Vaccines do not cure COVID-19.  They protect infected people against the worst symptoms of the disease.  We need for a treatment or a “sterilizing vaccine” that will kill the disease.

Everything I know about ivermectin leads to me think that it might be such a treatment, but I’m not a physician or an epidemiologist and I could be wrong.  If not there should be a search for a treatment—a search as intense as last year’s search for a vaccine.

The chief disadvantage of ivermectin from the standpoint of the pharmaceutical industry is that it is cheap, safe and not patented, which means that it is relatively unprofitable.  Using Occam’s Razor, this is the simplest explanation for the industry’s behavior.

LINKS

AAPS Letter to AMA Re: Ivermectin and COVID.

As US Prepares to Ban Ivermectin for Covid-19, More Countries in Asia Begin Using It by Nick Corbishley for Naked Capitalism.

US as Failed State: Covid Booster Shot Mess by Yves Smith for Naked Capitalism.

(more…)